Industry Reports
Lifescience and Healthcare Market Reports
Market research reports, forecasts, and competitive analysis for Lifescience and Healthcare.
21 reports found
Page 1 of 2
lhc-bsa0315
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: WILSON’S DISEASE FORECAST IN 28 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0314
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: PRIMARY IMMUNODEFICIENCY DISEASES FORECAST IN 23 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0313
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: PRADER–WILLI SYNDROME FORECAST IN 21 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0312
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: GROWTH HORMONE DEFICIENCY FORECAST IN 19 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0311
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: FRIEDREICH’S ATAXIA FORECAST IN 28 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0310
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: CUSHING’S SYNDROME FORECAST IN 25 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0309
$6,000
EPIOMIC EPIDEMIOLOGY SERIES: CONGENITAL ADRENAL HYPERPLASIA FORECAST IN 31 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0308
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ALPHA-1 ANTI-TRYPSIN DEFICIENCY FORECAST IN 18 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0307
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ADDISON'S DISEASE FORECAST IN 22 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0306
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: VENOUS THROMBOEMBOLISM FORECAST IN 24 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0305
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: PERIPHERAL ARTERIAL DISEASE FORECAST IN 22 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0304
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: HYPERTROPHIC CARDIOMYOPATHY FORECAST IN 26 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0303
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: HYPERTENSION FORECAST IN 19 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0302
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ATRIAL FIBRILLATION FORECAST IN 19 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics